Monopar Therapeutics Inc
F:1IY
Monopar Therapeutics Inc
F:1IY
Price:
1.85
EUR
Market Closed
Market Cap:
€32.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Monopar Therapeutics Inc
F:1IY
|
US |
|
Z
|
Zurich Insurance Group AG
XBER:ZFI1
|
CH |
|
Resmed Inc
OTC:RSMDF
|
US |
|
C
|
Cronos Group Inc
XBER:7CI
|
CA |
|
Paramount Global
F:0VVB
|
US |
|
A
|
Adocia SA
SWB:A89
|
FR |
|
Kairos Minerals Ltd
ASX:KAIDB
|
AU |
|
S
|
Swisscom AG
XBER:SWJA
|
CH |
|
B
|
BP PLC
DUS:BPE5
|
UK |
|
Aurora Innovation Inc
NASDAQ:AUR
|
US |
|
Magellan Aerospace Corp
TSX:MAL
|
CA |
|
Consolidated Edison Inc
NYSE:ED
|
US |
|
Tesla Inc
MIL:1TSLA
|
US |
|
Cementir Holding NV
F:3PC
|
IT |
|
Mitsubishi Electric Corp
TSE:6503
|
JP |
|
B
|
Baozun Inc
DUS:2BZA
|
CN |
|
S
|
Shanghai Industrial Holdings Ltd
XMUN:SGI
|
HK |
|
A
|
Agricultural Bank of China Ltd
XMUN:EK7
|
CN |
|
Life Healthcare Group Holdings Ltd
OTC:LTGHF
|
ZA |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of 1IY.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
1IY
Multiples-Based Value
Not Available
